Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Kaohsiung Chang Gung Memorial Hospital is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This action is assigned to 1 distinct examiner and is located within 1 distinct art unit. This data points to a specific and narrow prosecution focus for the hospital's current filings. The concentration of 1 pending office action in a single unit indicates that the hospital is not currently managing a diverse docket at the USPTO.
The busiest examiner for the hospital is WARD, AARON DUREL, who is managing 1 pending office action. Because the total number of pending actions is also 1, this examiner is the only one currently reviewing the hospital's applications. Having 1 pending office action in 1 distinct art unit suggests that the hospital's current intellectual property strategy is focused on a single technical innovation. The reliance on 1 distinct examiner means that progress is tied to a single examination process.
Practitioners should focus on the specific requirements of WARD, AARON DUREL to advance the 1 busiest examiner pending case. The Biotechnology & Pharmaceuticals portfolio is currently managed through 1 distinct art unit, simplifying administrative tracking but centralizing prosecution risk. The outcome of the 1 pending office action will be the primary determinant of the hospital's immediate success in securing patent rights in this technical field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WARD, AARON DUREL | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18229018 | METHOD FOR TREATING AND/OR PREVENTING HEARING LOSS BY USING TOLL-LIKE RECEPTOR 7 AND/OR 9 ANTAGONIST | WARD, AARON DUREL | 12d |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18229018 | METHOD FOR TREATING AND/OR PREVENTING HEARING LOSS BY USING TOLL-LIKE RECEPTOR 7 AND/OR 9 ANTAGONIST | WARD, AARON DUREL | 1636 | §102§103 | Final Rejection | 12d | Pending | Aug 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial